A comparative study of the efficacy and tolerability of amlodipine and lisinopril in the treatment of essential hypertension

Clinical Drug Investigation

Volumn 13, Issue SUPPL. 1, 1997, Pages 92-96

  Franchi, Massimo ^a   Di Perri, Tullio ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; LISINOPRIL;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BLOOD CHEMISTRY; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG TOLERABILITY; ELECTROCARDIOGRAM; ESSENTIAL HYPERTENSION; FEMALE; HEART RATE; HUMAN; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE;

EID: 0030744081     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199700131-00016     Document Type: Article

References (13)

1. Vetrovec G, Dailey S, Neal Kay G, et al. Hemodynamic and electrophysiologic effects of amlodipine, a new long-acting calcium antagonist: preliminary observations. Am Heart J 1989; 118: 1104
2. Webster J, Robb OB, Jeffers TA, et al. Once daily amlodipine in the treatment of mild to moderate hypertension. Br J Clin Pharmacol 1987; 24: 713-9
3. Mroczek WJ, Burris JF, Allemby KS. A double-blind evaluation of the effect of amlodipine on ambulatory blood pressure in hypertension patients. J Cardiovasc Pharmacol 1988; 12 Suppl. 7: S79
4. Burges RA, Dodd MG. Amlodipine. Cardiovasc Drug Rev 1990; 8: 25-34
5. Ferguson RK, Vlasses PH, Rotmensch HH. Clinical application of the ACE inhibitors. Am J Med 1984; 77: 690-8
6. Skeggs Jr LT. Historical overview of the renin-angiotensin system. In: Doyle AE, Bearn AG, editors. Hypertension and the angiotensin system: therapeutic approaches. New York: Raven Press, 1984: 31-45
7. Nayler WG, Dillon JS. Calcium antagonists and their mode of action: an historical overview. Br J Clin Pharmacol 1986; 21 Suppl. 2: 9-108S
8. Singh BN. The mechanism of action of calcium antagonists relative to their clinical application. Br J Clin Pharmacol 1986; 21 Suppl. 2: 109-22S
9. Zusman RM. Effects of converting-enzyme inhibitors on the renin-angiotensin-aldosterone, bradykinin, and arachidonic acid-prostaglandin system: correlation of chemical structure and biologic activity. Am J Kidney Dis 1987; 10 Suppl. 1: 13-23
10. Romero JC, Ruilopa RM, Bentley MB. Comparison of the effects of calcium antagonist and converting enzyme inhibitors on renal function under normal and hypertensive conditions. Am J Cardiol 1988; 62: 59-68G
11. Frohlich ED. Angiotensin converting enzyme inhibitors: present and future. Hypertension 1989; 13 Suppl. I: I125-30
12. Gustafsson D. Microvascular mechanisms involved in calcium antagonist edema formation. J Cardiovasc Pharmacol 1987; 10 Suppl. 1: S121-31
13. Opie LH. Clinical use of calcium channel antagonist drugs. Calcium channel antagonists, part II: side effects and contraindications, drug interactions and combinations, 2nd ed. Boston: Kluwer Academic Publishers, 1990: 193-218